EXTON, PA.  September 28, 2020. Megna Health, a medical technology company based in Exton, PA, announced today that its Rapid COVID-19 Antigen Kit has been CE certified for European market. 

Megna Health’s Rapid COVID-19 Antigen Test detects is a lateral flow immunoassay intended for rapid qualitative detection of nucleocapsid antigens from COVID-19 in human nasal swab, throat swab and sputum from individuals who are suspected of COVID-19 within the first seven days of the onset of symptoms. Results will be visually shown within 30 minutes without utilizing addiotnal equipment.

CE Certification (CE Marking) is the approval process of marketing medical and diagnostic products within the European Union.

Please contact us at info@megnahealth.com if you have any questions.


1 Comment

Megna Health Announces CE Certification of its Rapid COVID-19 Antigen Test – WellTree Molecular Group, LLC · January 8, 2021 at 10:21 am

[…] Read full article here: Megna Health Announces CE Certification of its Rapid COVID-19 Antigen Test […]

Comments are closed.